Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Transactions of the American Clinical and Climatological Association|June 6, 2008
Enhancing or eliminating signals for cell survival to treat diseaseDavid J Tweardy, Naijie JingJournal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Unique structural determinants for Stat3 recruitment and activation by the granulocyte colony-stimulating factor receptor at phosphotyrosine ligands 704 and 744Huang Shao, Xuejun Xu, Naijie Jing, et al.Current Pharmaceutical Design|August 17, 2005
Rational drug design of G-quartet DNA as anti-cancer agentsNaijie Jing, Wei Sha, Yidong Li, et al.Cancer Research|September 18, 2004
G-quartet oligonucleotides: a new class of signal transducer and activator of transcription 3 inhibitors that suppresses growth of prostate and breast tumors through induction of apoptosisNaijie Jing, Yidong Li, Weijun Xiong, et al.The Prostate|July 11, 2008
T40214/PEI complex: a potent therapeutics for prostate cancer that targets STAT3 signalingPriya Weerasinghe, Yifei Li, Yongli Guan, et al.Molecular Cancer Therapeutics|March 1, 2006
Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancerNaijie Jing, Qiqing Zhu, Ping Yuan, et al.DNA and Cell Biology|December 9, 2003
Targeting Stat3 with G-quartet oligodeoxynucleotides in human cancer cellsNaijie Jing, Yidong Li, Xuejun Xu, et al.The Journal of Biological Chemistry|February 18, 2004
Structural requirements for signal transducer and activator of transcription 3 binding to phosphotyrosine ligands containing the YXXQ motifHuang Shao, Xuejun Xu, Mary-Ann A Mastrangelo, et al.Transactions of the American Clinical and Climatological Association|October 5, 2022
DRUGGING "UNDRUGGABLE" DISEASE-CAUSING PROTEINS: FOCUS ON SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION (STAT) 3David J TweardyPageof 12